Synthesis and biological evaluation of analogues of M6G

Eur J Med Chem. 2011 Sep;46(9):4035-41. doi: 10.1016/j.ejmech.2011.05.076. Epub 2011 Jun 12.

Abstract

Synthesis and biological evaluation of new derivatives of Morphine-6-Glucuronide (M6G) are described. M6G is an active metabolite of morphine which displays more analgesia than morphine with a superior side effect profile but with a less efficiently BBB penetration. These phenomena could be explained by the presence of the glucuronide moiety, which confers a higher hydrophilic character compare to morphine. In this context, we have prepared three analogues of M6G possessing a tetrazole, an oxadiazole, and a triazolopyrimidine moiety instead of the carboxylic acid function on position 5 of the sugar. These three analogues showed higher analgesic properties than morphine and M6G even by oral administration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / chemical synthesis*
  • Analgesics, Opioid / pharmacokinetics
  • Analgesics, Opioid / pharmacology*
  • Animals
  • Blood-Brain Barrier
  • Magnetic Resonance Spectroscopy
  • Male
  • Mice
  • Morphine Derivatives / chemical synthesis*
  • Morphine Derivatives / pharmacokinetics
  • Morphine Derivatives / pharmacology*
  • Spectrometry, Mass, Electrospray Ionization

Substances

  • Analgesics, Opioid
  • Morphine Derivatives
  • morphine-6-glucuronide